nach oben

Erschienen in:

10.03.2016 | Demenz | Fortbildung

Neurologische Kasuistik

Motorische Unruhe bei Demenz

verfasst von: Dr. med. Peter Franz

Erschienen in: NeuroTransmitter | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Auszug

Ein 80-jähriger verheirateter Rentner, der wegen eines schweren demenziellen Syndroms seit zwei Jahren in einer geschlossenen Station eines Pflegeheimes lebt, wurde wegen zunehmender Gangstörung und motorischer Unruhe mit ständigem Herumwandern vorgestellt. Er nahm nur wechselnd am Essen teil und verbrachte einen großen Teil der Tages- und Nachtzeit mit scheinbar ungerichtetem Herumlaufen. Wechselnd kam es zu aggressivem Verhalten gegenüber Mitpatienten. …

Sanford JR. Tolerance of debility in elderly dependants by supporters at home; Its significance for hospital practice. BMJ 3: 471–473, 1975PubMedPubMedCentralCrossRef

Cohen-Mansfield J, Billig N. Agitated behaviors in the elderly. I. A conceptual review. J Am Geriatr Soc 34(10): 711–721, 1986PubMedCrossRef

Hope RA, Fairburn CG. The nature of wandering in dementia: A community-based study. Int J Geriatr Psychiatry 5: 239–245, 1990CrossRef

Martino-Salzman D, Blasch BB, Morris RD, McNeal LW: Travel behavior of nursing home residents perceived as wanderers and non-wanderers. Gerontologist 31: 666–672, 1991CrossRef

Hope T, Tilling KM, Gedling K, Keene JM, Cooper SD, Fairburn CG. The structure of wandering in dementia. Int J Geratr Psychiatry 9: 149–155, 1994CrossRef

Augustine, J. R. Circuitry and functional aspects of the insular lobe in primates including humans. Brain Res Brain Res. Rev 22: 229–244, 1996PubMedCrossRef

Algase DL, Kupferschmid B, Beel-Bates CA, Beattie ER. Estimates of stability of daily wandering behavior among cognitively impaired long-term care residents. Nurs Res 46(3): 172–178, 1997PubMedCrossRef

Linton AD, Matteson MA, Byers V. The relationship between premorbid life-style and wandering behaviors in institutionalized people with dementia. Aging (Milano 9(6): 415–418, 1997

Klein DA, Steinberg M, Galik E, Steele C, Sheppard JM, Warren A, Rosenblatt A, Lyketsos CG. Wandering behaviour in community-residing persons with dementia. Int J Geriatr Psychiatry. 114(4):272–279, 1999CrossRef

10.

Nimchinsky EA, Gilissen E, Allman JM, Perl DP, Erwin JM, Hof PR. A neuronal morphologic type unique to humans and great apes. Proc Natl Acad Sci USA 96: 5268–5273, 1999PubMedPubMedCentralCrossRef

11.

Kiely DK, Morris JN, Algase DL. Resident characteristics associated with wandering in nursing homes. Int J Geriatr Psychiatry 15(11): 1013–1020, 2000PubMedCrossRef

12.

Colombo M, Vitali S, Cairati M, Perelli-Cippo R, Bessi O, Gioia P, Guaita A. Wanderers: features, findings, issues. Arch Gerontol Geriatr Suppl 7:99–106, 2001CrossRef

13.

Hope T, Keene J, McShane RH, Fairburn CG, Gedling K, Jacoby R. Wandering in dementia: A longitudinal study. Int Psychogeriatr 13(2): 137–147, 2001PubMedCrossRef

14.

Rossi P, Serrao M, Pozzessere G: Gabapentin-induced worsening of neuropsychiatric symptoms in dementia with Lewy bodies: case reports. Eur Neurol 47:56–57, 2002PubMedCrossRef

15.

Fhager B, Meiri IM, Sjögren M, Edman A. Treatment of aggressive behavior in dementia with the anticonvulsant topiramate: a retrospective pilot study. Int Psychogeriatr 15(3):307–309, 2003PubMedCrossRef

16.

Gitlin LN, Liebman J, Winter L. Are environmental interventions effective in the management of Alzheimer’s disease and related disorders?: a synthesis of the evidence. Alzheimers Care Today 4:85–107, 2003

17.

Lai CK, Arthur DG. Wandering behaviour in people with dementia. J Adv Nurs 44(2): 173–182, 2003PubMedCrossRef

18.

Assal F, Alarcon M, Solomon EC, Masterman D, Geschwind DH, Cummings JL. Association of the serotonin transporter and receptor gene polymorphisms in neuropsychiatric symptoms in Alzheimer disease. Arch Neurol 61: 1249–1253, 2004PubMed

19.

Aud MA. Dangerous wandering: elopements of older adults with dementia from long-term care facilities. Am J Alzheimers Dis Other Demen 19(6): 361–368. 2004PubMedCrossRef

20.

Lyketsos CG, Rosenblatt A, Rabins P. Forgotten frontal lobe syndrome or ‘Executive Dysfunction Syndrome’. Psychosomatics 45:247–255, 2004PubMedCrossRef

21.

Sink KM, Covinsky KE, Newcomer R, Yaffe K, Ethnic differences in the prevalence and pattern of dementia-related behaviors. J Am Geriatr Soc 52: 1277–1283, 2004PubMedCrossRef

22.

Aulakh JS, Hawkins JW, Athwal HS, Sheikh JI, Yesavage J, and Tinklenberg JR. Tolerability and effectiveness of lamotrigine in complex elderly patients. J Geriatr Psychiatry Neurol 18(1):8–11, 2005PubMedCrossRef

23.

Beattie ER, Song J, LaGore S. A comparison of wandering behavior in nursing homes and assisted living facilities. Res Theory Nurs Pract 19(2): 181–196, 2005PubMedCrossRef

24.

Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlledtrials. JAMA 294(15): 1934–1943, 2005PubMedCrossRef

25.

Alsop DC, Fearing MA, Johnson K, Sperling R, Fong TG, Inouye SK. The role of neuroimaging in elucidating delirium pathophysiology. J Gerontol A Biol Sci Med Sci 61(12): 1287–1293, 2006PubMedCrossRef

26.

Franco KN, Messinger-Rapport B. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. J Am Med Dir Assoc 7(3):201–202, 2006PubMedCrossRef

27.

Schneider LS, Tariot PN, Dagerman KS, Davis SM, Hsiao JK, Ismail MS, et al. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer’s disease. N Engl J Med 355:1525–1538, 2006PubMedCrossRef

28.

Siddiqi N, House AO, Holmes JD. Occurrence and outcome of delirium in medical in-patients: a systematic literature review. Age Ageing 35: 350–364, 2006PubMedCrossRef

29.

Wick JY, Zanni GR. Aimless excursions: wandering in the elderly. Consult Pharm Aug;21(8):608–12, 615-618, 2006PubMedCrossRef

30.

Algase DL, Moore HD, Vandeweerd C, Gavin-Dreschnack DJ. Mapping the maze of terms and definitions in dementia-related wandering. Aging and Mental Health 11 (6): 686–698, 2007PubMedCrossRef

31.

Forester B, Vanelli M, Hyde J, Perez R, Ahokpossi C, Sribney W, Adkison L. Report on an open-label prospective study of divalproex sodium for the behavioraland psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication. Am J Geriatr Pharmacother 5(3): 209–217, 2007PubMedCrossRef

32.

Schonfeld L, King-Kallimanis B, Brown LM, Davis DM, Kearns WD, Molinari VA, Werner DH, Beattie ER, Nelson AL. Wanderers with cognitive impairment in Department of Veterans Affairs nursing home care units. J Am Geriatr Soc 55(5):692–699, 2007PubMedCrossRef

33.

Zuidema SU, Derksen E, Verhey FR, Koopmans RT. Prevalence of neuropsychiatric symptoms in a large sample of Dutch nursing home patients with dementia. Int J Geriatr Psychiatry 22(7): 632–638, 2007PubMedCrossRef

34.

Zuidema S, Koopmans R, Verhey F. Prevalence and predictors of neuropsychiatric symptoms in cognitively impaired nursing home patients. J Geriatr Psychiatr Neurol 20 (1): 41–49, 2007CrossRef

35.

Algase DL, Antonakos C, Yao L, Beattie ER, Hong GR, Beel-Bates, CA. Are wandering and physically nonaggressive agitation equivalent? Am J Geriatr Psychiatry 16(4): 293–309, 2008PubMedCrossRef

36.

Belanger HG, King-Kallimanis B, Nelson AL, Schonfeld L, Scott SG, Vanderploeg RD. Characterizing wandering behaviors in persons with traumatic brain injury residing in veterans health administration nursing homes. Arch Phys Med Rehabil 89(2): 244–250, 2008PubMedCrossRef

37.

Edvardsson D, Winblad B, and Sandman PO. Person-centered care of people with severe Alzheimer’s disease: current status and ways forward. Lancet Neurol 7: 362–367, 2008PubMedCrossRef

38.

Eriksson S, Gustafson Y, Lundin-Olsson L. Risk factors for falls in people with and without a diagnose of dementia living in residential care facilities: a prospective study. Arch Gerontol Geriatr 46(3): 293–306, 2008PubMedCrossRef

39.

Gupta N, de Jonghe J, Schieveld J, Leonard M, Meagher D. Delirium phenomenology: what can we learn from the symptoms of delirium? J Psychosom Res 65(3): 215–222, 2008PubMedCrossRef

40.

Kim Y, Wilkins KM, Tampi RR. Use of gabapentin in the treatment of behavioural and psychological symptoms of dementia: a review of the evidence. Drugs Aging 25(3):187–196, 2008PubMedCrossRef

41.

Konovalov S, Muralee S, Tampi RR: Anticonvulsants for the treatment of behavioral and psychological symptoms of dementia: a literature review. Int Psychogeriatr 20:293–308, 2008PubMedCrossRef

42.

Song JA, Algase D. Premorbid characteristics and wandering behavior in persons with dementia. Arch Psychiatr Nurs;22(6):318–327, 2008PubMedCrossRef

43.

Tsoi T, Baillon S, Lindesay J. Early frontal executive impairment as a predictor of subsequent behavior disturbance in dementia. Am J Geriatr Psychiatry 16: 102–108, 2008PubMedCrossRef

44.

Algase DL, Antonakos CL, Beattie E, Beel-Bates CA, Yao L. New parameters for daytime wandering. Res Gerontol Nurs 2(1): 58–68, 2009PubMedCrossRef

45.

Ballard C, Corbett A, Chitramohan R, Aarsland D. Management of agitation and aggression associated with Alzheimer‘s disease: controversies and possible solutions. Curr Opin Psychiatry 22(6): 532–540, 2009PubMedCrossRef

46.

Ballard C, Hanney ML, Theodoulou M, Douglas S, McShane R, Kossakowski K, Gill R, Juszczak E, Yu LM, Jacoby R; DART-AD investigators. The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. Lancet Neurol 8(2):151–157, 2009PubMedCrossRef

47.

Chenoweth L, King MT, Jeon YH, Brodaty H, Stein-Parbury J, Norman R, Haas M, and Luscombe G. Caring for aged care resident study (CADRES) op person-centred care, dementia-care mapping, and usual care in dementia: A cluster-randomised trial. Lancet Neurol 8: 317–325, 2009PubMedCrossRef

48.

Rodda J, Morgan S, Walker Z. Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer‘s disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine. Int Psychogeriatr 21(5): 813–824, 2009PubMedCrossRef

49.

Taragano FE, Allegri RF, Krupitzki H, Sarasola DR, Serrano CM, Lon L, et al. Mild behavioral impairment and risk of dementia: a prospective cohort study of 358 patients. J Clin Psychiatry 70: 584–592, 2009PubMedPubMedCentralCrossRef

50.

Menon V, Uddin LQ. Saliency, switching, attention and control: a network model of insula function. Brain Struct Funct 214: 655–667, 2010PubMedPubMedCentralCrossRef

51.

Mowla A, Pani A. Comparison of topiramate and risperidone for the treatment of behavioral disturbances of patients with Alzheimer disease: a double-blind, randomized clinical trial. J Clin Psychopharmacol 30(1): 40–43, 2010PubMedCrossRef

52.

Scherder EJ, Bogen T, Eggermont LH, Hamers JP, Swaab DF. The more physical inactivity, the more agitation in dementia. Int Psychogeriatr 22(8):1203–1208, 2010PubMedCrossRef

53.

Wetzels RB, Zuidema SU, de Jonghe JF, Verhey FR, Koopmans RT. Course of neuropsychiatric symptoms in residents with dementia in nursing homes over 2-year period. Am J Geriatr Psychiatry 18(12): 1054–1065, 2010PubMedCrossRef

54.

Wetzels R, Zuidema S, Jansen I, Verhey F, Koopmans R. Course of neuropsychiatric symptoms in residents with dementia in long-term care institutions: a systematic review. Int Psychogeriatr 22(7): 1040–1053, 2010PubMedCrossRef

55.

Khachiyants N, Trinkle D, Son SJ, Kim KY. Sundown syndrome in persons with dementia: an update. Psychiatry Investig 8(4): 275–287, 2011PubMedPubMedCentralCrossRef

56.

O‘Neil ME, Freeman M, Christensen V, Telerant R, Addleman A, Kansagara D. An Systematic Evidence Review of Non-pharmacological Interventions for Behavioral Symptoms of Dementia [Internet]. Washington (DC): Department of Veterans Affairs 2011

57.

Seitz DP, Adunuri N, Gill SS, Gruneir A, Herrmann N, Rochon P. Antidepressants for agitation and psychosis in dementia. Cochrane Database Syst RevCD008191. doi: 10.1002/14651858.CD008191.pub2, 2011

58.

Wenzel-Seifert K, Wittmann M und Haen Ekkehard. Psychopharmakaassoziierte QTc-Intervall-Verlängerung und Torsade de Pointes. Dtsch Arztebl Int 108(41): 687–693, 2011PubMedPubMedCentral

59.

Corbett A, Husebo B, Malcangio M, Staniland A, Cohen-Mansfield J, Aarsland D, Ballard C. Assessment and treatment of pain in people with dementia. Nat Rev Neurol 8(5):264–274, 2012PubMedCrossRef

60.

Halek, M., Bartholomeyczik, S. Description of the behaviour of wandering in people with dementia living in nursing homes - A review of the literature. Scand J of Caring Sci 26(2): 404–413, 2012CrossRef

61.

Kales HC, Kim HM, Zivin K, Valenstein M, Seyfried LS, Chiang C, Cunningham F, Schneider LS, Blow FC. Risk of mortality among individual antipsychotics in patients with dementia. Am J Psychiatry 169(1): 71–79, 2012PubMedPubMedCentralCrossRef

62.

Kim EJ, Sidhu M, Gaus SE, Huang EJ, Hof PR, Miller BL, DeArmond SJ, Seeley WW. Selective frontoinsular von Economo neuron and fork cell loss in early behavioral variant frontotemporal dementia. Cereb. Cortex 22, 251–259, 2012PubMedPubMedCentralCrossRef

63.

Köpke S, Mühlhauser I, Gerlach A, Haut A, Haastert B, Möhler R, Meyer G. Effect of a guideline-based multicomponent intervention on use of physical restraints in nursing homes. A randomized controlled trial. JAMA. 307(20):2177–2184, 2012PubMedCrossRef

64.

Lester PE, Gariet A, and Kohen I. Wandering and elopement in nursing homes. Annals of Long Term Care, 20(3), 32–36, 2012

65.

Onder G, Liperoti R, Fialova D, Topinkova E, Tosato M, Danese P, Gallo PF, Carpenter I, Finne-Soveri H, Gindin J, Bernabei R, Landi F; SHELTER Project. Polypharmacy in nursing home in Europe: results from the SHELTER study. J Gerontol A Biol Sci Med Sci 67(6):698–704, 2012PubMedCrossRef

66.

Tosato M, Lukas A, van der Roest HG, Danese P, Antocicco M, Finne-Soveri H, Nikolaus T, Landi F, Bernabei R, Onder G. Association of pain with behavioral and psychiatric symptoms among nursing home residents with cognitive impairment: results from the SHELTER study. Pain 153(2): 305–310, 2012PubMedCrossRef

67.

Cooney C, Murphy S, Tessema H, Freyne A. Use of low-dose gabapentin for aggressive behavior in vascular and Mixed Vascular/Alzheimer Dementia. J Neuropsychiatry Clin Neurosci 25(2): 120–125, 2013PubMedCrossRef

68.

Brownie S, Nancarrow S. Effects of person-centred care on residents and staff in aged-care facilities: A systematic review. Clinical Interventions in Aging 8: 1–10, 2013PubMedPubMedCentralCrossRef

69.

Critchley HD, Harrison NA. Visceral influences on brain and behavior. Neuron 77, 624–638, 2013PubMedCrossRef

70.

Declercq T, Petrovic M, Azermai M, Vander Stichele R, De Sutter AI, van Driel ML, Christiaens T. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia. Cochrane Database Syst Rev CD007726. doi:10.1002/14651858.CD007726.pub2, 2013

71.

Landreville P, Voyer P, Carmichael PH. Relationship between delirium and behavioral symptoms of dementia. Int Psychogeriatr 25(4): 635–643, 2013PubMedCrossRef

72.

Maldonado JR. Neuropathogenesis of delirium: review of current etiologic theories and common pathways. Am J Geriatr Psychiatry. 21(12):1190–1222, 2013PubMedCrossRef

73.

Merims D, Nahari H, Ben-Ari G, Jamal S, Vigder C, Ben-Israel J. Wandering in a dementia special care unit: behavioral aspects and the risk of falling. Isr Med Assoc J 15(7):364–367, 2013PubMed

74.

Neyens J, Halfens R, Spreeuwenberg M, Meijers J, Luiking Y, Verlaan G, Schols J. Malnutrition is associated with an increased risk of falls and impaired activity in elderly patients in Dutch residential long-term care (LTC): a cross-sectional study. Arch Gerontol Geriatr 56(1):265–269, 2013PubMedCrossRef

75.

Peavy GM, Salmon DP, Edland SD, Tam S, Hansen LA, Masliah E, Galasko D, Hamilton JM. Neuropsychiatric features of frontal lobe dysfunction in autopsy-confirmed patients with lewy bodies and „pure“ Alzheimer disease. Am J Geriatr Psychiatry 21(6): 509–519, 2013PubMedPubMedCentralCrossRef

76.

Santillo AF, Nilsson C, Englund E. von Economo neurones are selectively targeted in frontotemporal dementia. Neuropathol. Appl. Neurobiol 39, 572–579, 2013PubMedPubMedCentralCrossRef

77.

Selbæk G, Engedal K, Bergh S. The prevalence and course of neuropsychiatric symptoms in nursing home patients with dementia: a systematic review. J Am Med Dir Assoc 14(3):161–169, 2013PubMedCrossRef

78.

Toot S, Devine M, Akporobaro A, Orrell M. Causes of hospital admission for people with dementia: a systematic review and meta-analysis. J Am Med Dir Assoc 14(7): 463–470, 2013PubMedCrossRef

79.

Trzepacz PT, Yu P, Bhamidipati PK, Willis B, Forrester T, Tabas L, et al. Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer’s disease. Alzheimers Dement 9: S95–104, 2013PubMedPubMedCentralCrossRef

80.

Balthazar ML, Pereira FR, Lopes TM, da Silva EL, Coan AC, Campos BM, et al. Neuropsychiatric symptoms in Alzheimer’s disease are related to functional connectivity alterations in the salience network. Hum Brain Mapp 35: 1237–1246, 2014PubMedCrossRef

81.

Cipriani G, Lucetti C, Nuti A, Danti S. Wandering and dementia. Psychogeriatrics 14(2):135–142, 2014PubMedCrossRef

82.

Corbett A, Burns A, Ballard C. Don‘t use antipsychotics routinely to treat agitation and aggression in people with dementia. BMJ 349: g6420, 2014PubMedCrossRef

83.

Khatib R, Santesso N, Pickard L, Osman O, Giangregorio L, Skidmore C, Papaioannou A. Fracture risk in long term care: a systematic review and meta-analysis of prospective observational studies. BMC Geriatr. 14:130. doi: 10.1186/1471-2318-14-130, 2014

84.

Lahmann NA, Heinze C, Rommel A. [Falls in German hospitals and nursing homes 2006-2013. Frequencies, injuries, risk assessment, and preventive measures]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 57(6):650–659, 2014PubMedCrossRef

85.

Livingston G, Kelly L, Lewis-Holmes E, Baio G, Morris S, Patel N, Omar RZ, Katona C, Cooper C. A systematic review of the clinical effectiveness and cost-effectiveness of sensory, psychological and behavioural interventions for managing agitation in older adults with dementia. Health Technol Assess 18(39):1–226, 2014CrossRef

86.

Porsteinsson AP, Drye LT, Pollock BG, Devanand DP, Frangakis C, Ismail Z, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Rabins PV, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG; CitAD Research Group. Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial. JAMA. 311(7):682–691, 2014PubMedPubMedCentralCrossRef

87.

Selbaek G, Engedal K, Benth JŠ, Bergh S. The course of neuropsychiatric symptoms in nursing-home patients with dementia over a 53-month follow-up period. Int Psychogeriatr 26(1):81–91, 2014PubMed

88.

Soto M, Andrieu S, Nourhashemi F, Ousset PJ, Ballard C, Robert P, Vellas B, Lyketsos CG, Rosenberg PB. Medication development for agitation and aggression in Alzheimer disease: review and discussion of recent randomized clinical trialdesign. Int Psychogeriatr 16:1–17, 2014

89.

Testad I, Corbett A, Aarsland D, Lexow KO, Fossey J, Woods B, Ballard C. The value of personalized psychosocial interventions to address behavioral and psychological symptoms in people with dementia living in care home settings: asystematic review. Int Psychogeriatr 26(7): 1083–1098, 2014PubMedCrossRef

90.

Yamakawa M, Yoshida Y, Higami Y, Shigenobu K, Makimoto K. Caring for early-onset dementia with excessive wandering of over 30 kilometres per day: a case report. Psychogeriatrics 14(4):255–260, 2014PubMedCrossRef

91.

White EB, Montgomery P. Electronic tracking for people with dementia: an exploratory study of the ethical issues experienced by carers in making decisions about usage. Dementia 13(2): 216–232, 2014PubMedCrossRef

92.

Ali N, Luther SL, Volicer L, Algase D, Beattie E, Brown LM, Molinari V, Moore H, Joseph I. Risk assessment of wandering behavior in mild dementia. Int J Geriatr Psychiatry. doi: 10.1002/gps.4336. [Epub ahead of print], 2015

93.

Antonsdottir IM, Smith J, Keltz M, Porsteinsson AP. Advancements in the treatment of agitation in Alzheimer‘s disease. Expert Opin Pharmacother 16(11): 1649–1656, 2015PubMedCrossRef

94.

Bossen AL, Kim H, Williams KN, Steinhoff AE, Strieker M. Emerging roles for telemedicine and smart technologies in dementia care. Smart Homecare Technol Telehealth 3: 49–57, 2015PubMedPubMedCentralCrossRef

95.

Cummings JL, Lyketsos CG, Peskind ER, Porsteinsson AP, Mintzer JE, Scharre DW, De La Gandara JE, Agronin M, Davis CS, Nguyen U, Shin P, Tariot PN, Siffert J. Effect of Dextromethorphan-Quinidine on agitation in patients with Alzheimer Disease dementia: A randomized clinical trial. JAMA. 2015 Sep 22-29;314(12):1242–1254, 2015PubMedCrossRef

96.

de Oliveira AM, Radanovic M, de Mello PC, Buchain PC, Vizzotto AD, Celestino DL, Stella F, Piersol CV, Forlenza OV. Nonpharmacological interventions to reduce behavioral and psychological symptoms of dementia: A systematic review. Biomed Res Int 2015:218980. doi: 10.1155/2015/218980. Epub Nov 29. 2015

97.

Graham ME. From wandering to wayfaring: Reconsidering movement in people with dementia in long-term care. Dementia (London) pii:1471301215614572. [Epub ahead of print], 2015

98.

Gu L. Nursing Interventions in Managing Wandering Behavior in Patients With Dementia: A Literature Review. Arch Psychiatr Nurs 29(6): 454–457, 2015PubMedCrossRef

99.

Kales HC, Gitlin LN, Lyketsos CG. Assessment and management of behavioral and psychological symptoms of dementia. BMJ 350:h369. doi:10.1136/bmj.h369, 2015

100.

Maust DT, Kim HM, Seyfried LS, Chiang C, Kavanagh J, Schneider LS, Kales HC. Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm. JAMA Psychiatry 72(5): 438–445, 2015PubMedCrossRef

101.

Newell J, Yesavage JA, Taylor JL, Kraemer HC, Munro CA, Friedman L, Rosenberg PB, Madore M, Chao SZ, Devanand DP, Drye LT, Mintzer JE, Pollock BG, Porsteinsson AP, Schneider LS, Shade DM, Weintraub D, Lyketsos CG, Noda A; CitAD Research Group. Sedation mediates part of Citalopram‘s effect on agitation in Alzheimer‘s disease. J Psychiatr Res 74:17–21, 2015PubMedCrossRef

102.

Nowrangi MA, Lyketsos CG, Rosenberg PB. Princeiples and management of neuropsychiatric symptoms in Alzheimer`s dementia. Alzheimers Res Ther 7: 12, 2015PubMedCentralCrossRef

103.

Panza F, Solfrizzi V, Seripa D, Imbimbo BP, Santamato A, Lozupone M, Prete C, Greco A, Pilotto A, Logroscino G. Progresses in treating agitation: a major clinical challenge in Alzheimer‘s disease. Expert Opin Pharmacother 16(17):2581–2588, 2015PubMedCrossRef

104.

Peters ME, Schwartz S, Han D, Rabins PV, Steinberg M, Tschanz JT, Lyketsos CG. Neuropsychiatric symptoms as predictors of progression to severe Alzheimer‘s dementia and death: the Cache County Dementia Progression Study. Am J Psychiatry 172(5): 460–465, 2015PubMedCrossRef

105.

Rao V, Koliatsos V, Ahmed F, Lyketsos C, Kortte K. Neuropsychiatric disturbances associated with traumatic brain injury: a practical approach to evaluation and management. Semin Neurol 35(1): 64–82, 2015PubMedCrossRef

106.

Uddin LQ. Salience processing and insular cortical function and dysfunction. Nat Rev Neurosci 16(1): 55–61, 2015PubMedCrossRef

107.

van Dalen-Kok AH, Pieper MJ, de Waal MW, Lukas A, Husebo BS, Achterberg WP. Association between pain, neuropsychiatric symptoms, and physical function in dementia: a systematic review and meta-analysis. BMC Geriatr 15: 49, 2015PubMedPubMedCentralCrossRef

108.

Schneider LS, Frangakis C, Drye LT, Devanand DP, Marano CM, Mintzer J, Mulsant BH, Munro CA, Newell JA, Pawluczyk S, Pelton G, Pollock BG, Porsteinsson AP, Rabins PV, Rein L, Rosenberg PB, Shade D, Weintraub D, Yesavage J, Lyketsos CG; CitAD Research Group. Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer‘s Disease With Aggression or Agitation: The CitAD Randomized Clinical Trial. Am J Psychiatry 15:appiajp201515050648.[Epub ahead of print], 2016

109.

Buchner DM, Larson EB. Falls and fractures in patients with Alzheimer-type dementia. JAMA 257(11):1492–1495, 1987PubMedCrossRef

110.

Hamers JP, Meyer G, Köpke S, Lindenmann R, Groven R, Huizing AR. Attitudes of Dutch, German and Swiss nursing staff towards physical restraint use in nursing home residents, a cross-sectional study. Int J Nurs Stud 46(2): 248–255, 2009PubMedCrossRef

111.

Brazil, K., Hasler, A., McAiney, C., Sturdy-Smith, C., Tettman, M. Perceptions of resident behavior problems and their clinical management in Long Term Care facilities. Journal of Mental Health and Aging, 9(1), 35–42, 2003

112.

Midorikawa A, Suzuki H, Hiromitsu K, Kawamura M. Wandering behavior of a severely demented patient with frontotemporal dementia. Neurocase 8:1–5, 2015

113.

Ata T, Terada S, Yokota O, Ishihara T, Fujisawa Y, Sasaki K, Kuroda S. Wandering and fecal smearing in people with dementia. Int Psychogeriatr 22(3):493–500, 2010PubMedCrossRef

114.

Roden DM. Predicting drug-induced QT prolongation and torsades de Pointes. J Physiol. 2015 Dec 14. doi: 10.1113/JP270526. [Epub ahead of print], 2015

115.

Heinrich S, Rapp K, Rissmann U, Becker C, König HH. Cost of falls in old age: a systematic review. Osteoporos Int 21(6): 891–902, 2010PubMedCrossRef

Titel: Neurologische Kasuistik
Motorische Unruhe bei Demenz
verfasst von: Dr. med. Peter Franz
Publikationsdatum: 10.03.2016
Verlag: Springer Medizin
Schlagwörter: Demenz
Agitiertheit
Demenz
Erschienen in: NeuroTransmitter / Ausgabe 3/2016
Print ISSN: 1436-123X
Elektronische ISSN: 2196-6397
DOI: https://doi.org/10.1007/s15016-016-5487-6

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

18.04.2024 | Arterielle Hypertonie | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Motorische Unruhe bei Demenz

Auszug

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Manche Gestagene können das Risiko für Meningeome erhöhen

Parkinson: Größere Studie bestätigt Genauigkeit von Hauttest

Update Neurologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Auszug

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2016

Medizinprodukt gegen Kopfschmerz

Die Alpen gerendert

Wann droht die Gewerbesteuerpflicht?

Terminservicestellen — ein erheblicher Strukturwandel

Für den Fachmann und alle Interessierten

Superwahljahr 2016

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Manche Gestagene können das Risiko für Meningeome erhöhen

Parkinson: Größere Studie bestätigt Genauigkeit von Hauttest

Update Neurologie